title: Positron emission tomography/computed tomography imaging and rheumatoid arthritis.
abstract: Rheumatoid arthritis (RA) is a phenotypically heterogeneous, chronic, destructive inflammatory disease of the synovial joints. A number of imaging tools are currently available for evaluation of inflammatory conditions. By targeting the upgraded glucose uptake of infiltrating granulocytes and tissue macrophages, positron emission tomography/computed tomography with fluorine-18 fluorodeoxyglucose ((18) F-FDG PET/CT) is available to delineate inflammation with high sensitivity. Recently, several studies have indicated that FDG uptake in affected joints reflects the disease activity of RA. In addition, usage of FDG PET for the sensitive detection and monitoring of the response to treatment has been reported. Combined FDG PET/CT enables the detailed assessment of disease in large joints throughout the whole body. These unique capabilities of FDG PET/CT imaging are also able to detect RA-complicated diseases. Therefore, PET/CT has become an excellent ancillary tool to assess disease activity and prognosis in RA.
authors.affiliation: PET/CT Center, Anhui Provincial Hospital, Hefei, Anhui, China.
authors.forename: Shi-Cun
authors.initials: SC
authors.lastname: Wang
authors.forename: Qiang
authors.initials: Q
authors.lastname: Xie
authors.forename: Wei-Fu
authors.initials: WF
authors.lastname: Lv
mesh_terms: D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000000981:diagnostic imaging*; D018450:Disease Progression; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography; D011379:Prognosis; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18
keywords: positron emission tomography; positron emission tomography/computed tomography; rheumatoid arthritis